Back to Trades
Sullivan Christopher Ryan
InsiderCIK 0001810417
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 10
- Buy transactions
- 0
- Sell transactions
- 14
- Companies
- 1
- Active
- 2025–2026
Across 10 filings between 2025–2026, Sullivan Christopher Ryan has disclosed $8.0M in transactions — all concentrated in Avalo Therapeutics, Inc. (AVTX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $3.3M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
10 loaded
| Sep 11 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Sell | $179.5K |
| Aug 19 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Sell | $1.5M |
| Jun 12 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Tax withheld | $1.8K |
| May 26 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Grant | $0 |
| May 11 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Sell | $448.8K |
| May 7 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Sell | $948.7K |
| Apr 3 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Sell | $270.6K |
| Mar 31 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Exercise | $114.5K |
| Mar 2 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Insider | Award | $1.9M |
| Dec 12 | AVTX Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | Tax withheld | $636 |
10 filings